Challenges for imaging angiogenesis.
暂无分享,去创建一个
[1] D M Shames,et al. Mammary carcinoma model: correlation of macromolecular contrast-enhanced MR imaging characterizations of tumor microvasculature and histologic capillary density. , 1996, Radiology.
[2] A. Kaider,et al. Vascular endothelial growth factor (VEGF) in human breast cancer: Correlation with disease‐free survival , 1997, International journal of cancer.
[3] D. Chaplin,et al. Anti-vascular approaches to solid tumour therapy: evaluation of combretastatin A4 phosphate. , 1999, Anticancer research.
[4] P. Vermeulen,et al. Clinical relevance of vascular endothelial growth factor and thymidine phosphorylase in patients with node-positive breast cancer treated with either adjuvant chemotherapy or hormone therapy. , 1999, The cancer journal from Scientific American.
[5] P. Carmeliet,et al. Molecular mechanisms of blood vessel growth. , 2001, Cardiovascular research.
[6] R. Davis,et al. In vivo detection and imaging of phosphatidylserine expression during programmed cell death. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[7] Dario Neri,et al. Targeting by affinity–matured recombinant antibody fragments of an angiogenesis associated fibronectin isoform , 1997, Nature Biotechnology.
[8] T. Henry. Science, medicine, and the future: Therapeutic angiogenesis , 1999 .
[9] R. Henriksson,et al. Vascular endothelial growth factor is of high prognostic value in node-negative breast carcinoma. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] L. Norton,et al. Immunophenotype of intraductal carcinoma. , 1996, Archives of pathology & laboratory medicine.
[11] P. Rao,et al. Expression of Tie2/Tek in breast tumour vasculature provides a new marker for evaluation of tumour angiogenesis. , 1998, British Journal of Cancer.
[12] M. Nguyen,et al. Regression of Metastatic Breast Cancer in a Patient Treated with the Anti-Angiogenic Drug Tnp-470 , 1999, Tumori.
[13] H. Augustin,et al. Heterogeneity of angiogenesis and blood vessel maturation in human tumors: implications for antiangiogenic tumor therapies. , 2000, Cancer research.
[14] David A. Cheresh,et al. Detection of tumor angiogenesis in vivo by αvβ3-targeted magnetic resonance imaging , 1998, Nature Medicine.
[15] A. Alavi,et al. Role of radionuclide imaging in trials of antiangiogenic therapy. , 2000, Academic radiology.
[16] M. Dewhirst,et al. Initial stages of tumor cell-induced angiogenesis: evaluation via skin window chambers in rodent models. , 2000, Journal of the National Cancer Institute.
[17] K W Ferrara,et al. Evaluation of tumor angiogenesis with US: imaging, Doppler, and contrast agents. , 2000, Academic radiology.
[18] J. Isner,et al. Stimulation of peripheral angiogenesis by vascular endothelial growth factor (VEGF). , 1998, VASA. Zeitschrift fur Gefasskrankheiten.
[19] J. Folkman. New perspectives in clinical oncology from angiogenesis research. , 1996, European journal of cancer.
[20] Michal Neeman,et al. In Vivo Prediction of Vascular Susceptibility to Vascular Endothelial Growth Factor Withdrawal Magnetic Resonance Imaging of C6 Rat Glioma in Nude Mice , 1999 .
[21] N. van Bruggen,et al. Magnetic resonance imaging detects suppression of tumor vascular permeability after administration of antibody to vascular endothelial growth factor. , 1998, Cancer investigation.
[22] R. Gilles,et al. Ductal carcinoma in situ: MR imaging-histopathologic correlation. , 1995, Radiology.
[23] G. Sledge,et al. Redefining the target: chemotherapeutics as antiangiogenics. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[24] T. Haas,et al. Extracellular matrix-driven matrix metalloproteinase production in endothelial cells: implications for angiogenesis. , 1999, Trends in cardiovascular medicine.
[25] R Weissleder,et al. Imaging of tumour neovasculature by targeting the TGF-beta binding receptor endoglin. , 2000, European journal of cancer.
[26] K. Miles,et al. Tumour angiogenesis and its relation to contrast enhancement on computed tomography: a review. , 1999, European journal of radiology.
[27] C. Verschraegen,et al. Complete remission of metastatic cervical cancer with the angiogenesis inhibitor TNP-470. , 1998, The New England journal of medicine.
[28] Chien-Nan Lee,et al. Vascularity index as a novel parameter for the in vivo assessment of angiogenesis in patients with cervical carcinoma , 1999, Cancer.
[29] E. Fishman,et al. Application of CT in the investigation of angiogenesis in oncology. , 2000, Academic radiology.
[30] N. Weidner,et al. Tumoural vascularity as a prognostic factor in cancer patients: the evidence continues to grow , 1998, The Journal of pathology.
[31] A R Padhani,et al. In vivo monitoring of tumor angiogenesis with MR imaging. , 2000, Academic radiology.
[32] R. Kerbel,et al. Consequences of angiogenesis for tumor progression, metastasis and cancer therapy. , 1995, Anti-cancer drugs.